These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2960696)

  • 1. PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro.
    Laurence J; Kulkosky J; Friedman SM; Posnett DN; Ts'o PO
    J Clin Invest; 1987 Dec; 80(6):1631-9. PubMed ID: 2960696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.
    Thompson KA; Strayer DR; Salvato PD; Thompson CE; Klimas N; Molavi A; Hamill AK; Zheng Z; Ventura D; Carter WA
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):580-7. PubMed ID: 8874076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion.
    Laurence J; Friedman SM; Chartash EK; Crow MK; Posnett DN
    J Clin Invest; 1989 Jun; 83(6):1843-8. PubMed ID: 2470786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Tolerization" of human T-helper cell clones by chronic exposure to alloantigen: culture conditions dictate autocrine proliferative status but not acquisition of cytotoxic potential and suppressor-induction capacity.
    Pawelec G; Brocker T; Busch FW; Bühring HJ; Fernandez N; Schneider EM; Wernet P
    J Mol Cell Immunol; 1988; 4(1):21-34. PubMed ID: 2977949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease.
    Carter WA; Ventura D; Shapiro DE; Strayer DR; Gillespie DH; Hubbell HR
    Int J Immunopharmacol; 1991; 13 Suppl 1():69-76. PubMed ID: 1688087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
    Mitsuya H; Broder S
    AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ampligen inhibits human herpesvirus-6 in vitro.
    Ablashi DV; Berneman ZN; Williams M; Strayer DR; Kramarsky B; Suhadolnik RJ; Reichenbach N; Hiltzges P; Komaroff AL
    In Vivo; 1994; 8(4):587-91. PubMed ID: 7893986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PolyI:C and mouse survivin artificially embedding human 2B peptide induce a CD4+ T cell response to autologous survivin in HLA-A*2402 transgenic mice.
    Kasamatsu J; Takahashi S; Azuma M; Matsumoto M; Morii-Sakai A; Imamura M; Teshima T; Takahashi A; Hirohashi Y; Torigoe T; Sato N; Seya T
    Immunobiology; 2015 Jan; 220(1):74-82. PubMed ID: 25257859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the discovery of HTLV-III for the treatment of AIDS.
    Yarchoan R; Mitsuya H; Matsushita S; Broder S
    Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The race between initial T-helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set-point.
    Korthals Altes H; Ribeiro RM; de Boer RJ
    Proc Biol Sci; 2003 Jul; 270(1522):1349-58. PubMed ID: 12965025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance.
    Miedema F
    Immunodefic Rev; 1992; 3(3):173-93. PubMed ID: 1354968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of alloantigen-stimulated anti-human immunodeficiency virus activity is associated with HLA-A*02 expression.
    Grene E; Pinto LA; Cohen SS; Mac Trubey C ; Trivett MT; Simonis TB; Liewehr DJ; Steinberg SM; Shearer GM
    J Infect Dis; 2001 Feb; 183(3):409-16. PubMed ID: 11133372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR-4-associated alloreactivity of an HLA-DR-3-restricted human tetanus toxoid-specific T cell clone: inhibition of both reactivities by an alloantiserum.
    Umetsu DT; Yunis EJ; Matsui Y; Jabara HH; Geha RS
    Eur J Immunol; 1985 Apr; 15(4):356-61. PubMed ID: 3157581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
    Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agents for treating human immunodeficiency virus infection.
    Acosta EP; Fletcher CV
    Am J Hosp Pharm; 1994 Sep; 51(18):2251-67; quiz 2286-7. PubMed ID: 7801986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro.
    Montaner LJ; Griffin P; Gordon S
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3393-400. PubMed ID: 7527834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.
    Bermejo M; López-Huertas MR; García-Pérez J; Climent N; Descours B; Ambrosioni J; Mateos E; Rodríguez-Mora S; Rus-Bercial L; Benkirane M; Miró JM; Plana M; Alcamí J; Coiras M
    Biochem Pharmacol; 2016 Apr; 106():30-45. PubMed ID: 26851491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiviral strategies in the replication of human immunodeficiency virus].
    Wainberg MA; Bour S; Geleziunas R; Bentwich Z
    Union Med Can; 1992; 121(5):307-9, 312-4. PubMed ID: 1279875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low level lead exposure in vitro stimulates the proliferation and expansion of alloantigen-reactive CD4(high) T cells.
    McCabe MJ; Singh KP; Reiners JJ
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):219-31. PubMed ID: 11749121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.